# Hassan Abolhassani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hassan-abolhassani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 82,087 |
| Field | Immunodeficiency and Autoimmune Disorders |
| h-index | 83 |
| i10-index | 323 |
| Last Known Institution | University of Bonn |
| OpenAlex ID | https://openalex.org/A5051258190 |
| ORCID iD | https://orcid.org/0000-0002-4838-0407 |
| Works | 595 |

## Researcher papers

Showing 12 of 27.

- [Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-incidence-prevalence-years-lived-with-disability-ylds-disability-adjusted/)
- [Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-regional-and-national-burden-of-diabetes-from-1990-to-2021-with/)
- [Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050](https://scholariq.org/papers/global-burden-of-bacterial-antimicrobial-resistance-1990-2021-a-systematic/)
- [Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-burden-and-strength-of-evidence-for-88-risk-factors-in-204-countries-and/)
- [Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019](https://scholariq.org/papers/cancer-incidence-mortality-years-of-life-lost-years-lived-with-disability-and/)
- [Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/global-age-sex-specific-fertility-mortality-healthy-life-expectancy-hale-and/)
- [Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-regional-and-national-burden-of-disorders-affecting-the-nervous-system/)
- [Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/burden-of-disease-scenarios-for-204-countries-and-territories-2022-2050-a/)
- [Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-age-sex-specific-mortality-life-expectancy-and-population-estimates-in/)
- [The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/the-global-burden-of-cancer-attributable-to-risk-factors-2010-19-a-systematic/)
- [Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019](https://scholariq.org/papers/global-burden-of-chronic-respiratory-diseases-and-risk-factors-1990-2019-an/)
- [Five insights from the Global Burden of Disease Study 2019](https://scholariq.org/papers/five-insights-from-the-global-burden-of-disease-study-2019/)

## Researcher topics

- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

## Researcher university

- [University of Bonn](https://scholariq.org/institutions/university-of-bonn/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.